Recurrent low back pain accounts for disproportionate healthcare costs in Polish working-age adults
A 3-year (2019-2021) observational cohort study analyzed Polish National Health Fund and hospital data to estimate the direct costs of recurrent low back pain (LBP) in working-age adults (21-65 years) with LBP-related ICD-10 diagnoses. The study compared recurrent LBP cases to non-recurrent cases, with the primary outcome being estimated direct costs. The total sample size was not reported.
The analysis found the mean annual direct cost for all working-age LBP individuals in Poland was €184,986,519. Of this, recurrent LBP accounted for €13,699,529 (95% CI: €9,829,766–17,522,323). Although recurrent LBP cases comprised only 24.51% of all LBP cases, they accounted for 38.37% of total LBP costs and 54.28% of medical services. The median cost-per-visit was significantly higher for recurrent LBP compared to non-recurrent LBP. Patients over 35 years old accounted for 34.72% of total LBP expenses and two-fifths of all medical services, with physiotherapy services being the predominant type of outpatient visit.
Safety and adverse events were not reported. Key limitations include the observational design, which cannot establish causality, and the lack of reported sample size and specific effect sizes. The findings are specific to the Polish healthcare system and may not be generalizable to other settings.
For clinicians, this study quantifies the disproportionate resource use associated with recurrent LBP in a working-age population. The data suggest that recurrent cases, while a minority of patients, drive a large share of costs and service utilization, particularly in adults over 35. This underscores the potential clinical and economic importance of effective management strategies to prevent recurrence.